EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Sophia Bielesch iD, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling iD, Holger Bronger, Marion Kiechle und 2 weitere

Molecular Oncology · 2026

DOI: 10.1002/1878-0261.70227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2026. Verfasst von Sophia Bielesch und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics, Technical University of Munich, Germany. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Ovarian Neoplasms, Keratin-19, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wilhelm Sander-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐grade serous ovarian cancer (HGSOC) is the most prevalent and lethal subtype of epithelial ovarian cancer (EOC), characterised by extensive peritoneal metastasis. The intermediate filament keratin 19 (KRT19) has been linked to tumour progression and chemoresistance in various cancers. However, its role varies across tumour types and remains unclear for HGSOC. We evaluated KRT19 protein expression in 199 HGSOC patients and correlated findings with clinical outcomes. In vitro , we assessed the effects of KRT19 on tumour‐associated mechanisms, including proliferation, migration, adhesion, and spheroid formation. A xenograft mouse model was used to assess tumour burden in vivo . Publicly available datasets enabled in silico validation. KRT19 was significantly overexpressed in HGSOC, and high expression was associated with reduced overall survival. In vivo , KRT19‐overexpression increased peritoneal tumour burden. In vitro and ex vivo , KRT19 induced a hybrid epithelial phenotype through enhanced epithelial–mesenchymal plasticity (EMP), promoting adhesion, migration, and spheroid integrity, thereby potentially supporting metastatic processes. Further, KRT19 could contribute to paclitaxel resistance. Altogether, KRT19 represents a potential independent prognostic marker and therapeutic target to inhibit metastatic dissemination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmOvarian NeoplasmsKeratin-19Biomarkers, TumorCystadenocarcinoma, SerousHumansFemaleAnimalsPrognosisCell Line, TumorMiceCell MovementNeoplasm MetastasisCell ProliferationEpithelial-Mesenchymal TransitionMiddle AgedCell AdhesionNeoplasm Grading

Stichwörter der Autor:innen

chemoresistanceepithelial–mesenchymal plasticitykeratin 19ovarian cancer

Substanzen

Keratin-19Biomarkers, TumorKRT19 protein, human

Autor:innen und Institutionen

  • Department of Gynaecology and Obstetrics, Technical University of Munich, Germany.
  • Faculty of Medicine, Institute for Surgical Pathology, Medical Centre, University of Freiburg, Germany.
  • German Cancer Consortium (DKTK), Partner Site Munich, a partnership between DKFZ and Technical University of Munich, Heidelberg, Germany.

ORCID-Profile: Sophia Bielesch, Oliver Schilling

Förderung

  • Wilhelm Sander-Stiftung

Zitieren

APA

Bielesch, S., Vogel, I., Nokodian, S., Moeller, J., Blechschmidt, A., Hecht, V., Kuentzel, V., Thiedig, K., Schwab, M., Schilling, O., Bronger, H., Kiechle, M., Magdolen, V., & Dreyer, T. (2026). Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer. Molecular Oncology. https://doi.org/10.1002/1878-0261.70227

Vancouver

Bielesch S, Vogel I, Nokodian S, Moeller J, Blechschmidt A, Hecht V, et al. Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer. Molecular Oncology. 2026. doi:10.1002/1878-0261.70227

BibTeX
@article{Bielesch2026,
  author = {Bielesch, Sophia and Vogel, Isabel and Nokodian, Sina and Moeller, Johanna and Blechschmidt, Antonia and Hecht, Vicky and Kuentzel, Vanessa and Thiedig, Katharina and Schwab, Melissa and Schilling, Oliver and Bronger, Holger and Kiechle, Marion and Magdolen, Viktor and Dreyer, Tobias},
  title = {Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer},
  journal = {Molecular Oncology},
  year = {2026},
  doi = {10.1002/1878-0261.70227}
}
Kostenlos starten →